|
Market Closed -
Nasdaq
00:00:00 26/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 1.920 USD | +3.23% |
|
+6.08% | -73.91% |
| 08-13 | Karyopharm Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-13 | Karyopharm Therapeutics Inc., Q2 2026 Earnings Call, Aug 13, 2026 |
| Market Cap | 42.19M 36.15M 33.87M 30.94M 58.39M 4.02B 58.97M 400M 156M 2.03B 158M 155M 6.72B | P/E 2026 * |
-0.4x | P/E 2027 * | -0.78x |
|---|---|---|---|---|---|
| Enterprise Value | 42.19M 36.15M 33.87M 30.94M 58.39M 4.02B 58.97M 400M 156M 2.03B 158M 155M 6.72B | EV / Sales 2026 * |
0.31x | EV / Sales 2027 * | 0.24x |
| Free-Float |
95.33% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Karyopharm Therapeutics Inc.
| 1 day | +1.61% | ||
| 1 week | +6.08% | ||
| 1 month | -74.09% | ||
| 3 months | -76.47% | ||
| 6 months | -80.93% | ||
| Current year | -73.91% |
| 1 week | 1.82 |  | 2.02 |
| 1 month | 1.79 | | 7.84 |
| Current year | 1.79 | | 10.99 |
| 1 year | 1.79 | | 10.99 |
| 3 years | 1.79 | | 29.25 |
| 5 years | 1.79 | | 220.95 |
| 10 years | 1.79 | | 444.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Paulson
CEO | Chief Executive Officer | 58 | 03/05/2021 |
Lori Macomber
DFI | Director of Finance/CFO | 55 | 03/01/2025 |
Amama Sadiq
CTO | Chief Tech/Sci/R&D Officer | - | 01/04/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Barry Greene
BRD | Director/Board Member | 62 | 01/01/2013 |
| Director/Board Member | 61 | 01/04/2013 | |
Garen Bohlin
BRD | Director/Board Member | 78 | 03/10/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 28/07/26 | Sell | Executive/Senior Manager | -189 | 0.0008% | ||
| 14/05/26 | Sell | Controller/Auditor | -53 | 0.0002% | ||
| 17/02/26 | Sell | Executive/Senior Manager | 378 | 0.0021% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.23% | +6.08% | -69.52% | -90.79% | 42.19M | |
| +0.61% | +3.43% | +41.41% | +0.28% | 82.73B | |
| +2.68% | +29.00% | -19.83% | -34.19% | 57.94B | |
| +14.36% | +146.40% | +485.66% | +40.99% | 55.45B | |
| +0.76% | +2.39% | +0.08% | +35.11% | 52.57B | |
| +1.86% | +4.04% | +13.58% | +175.04% | 48.94B | |
| +1.21% | +5.56% | +58.47% | -15.87% | 32.23B | |
| +1.36% | +5.04% | +52.54% | +101.96% | 25.94B | |
| +0.60% | +4.98% | +0.65% | +188.89% | 22.1B | |
| +3.89% | +2.58% | +61.60% | +116.01% | 16.55B | |
| Average | +2.81% | +16.00% | +62.46% | +51.74% | 39.45B | |
| Weighted average by Cap. | +3.15% | +21.84% | +86.58% | +48.04% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 136M 116M 109M 99.47M 188M 12.93B 190M 1.28B 500M 6.52B 509M 498M 21.6B | 174M 149M 139M 127M 240M 16.55B 243M 1.64B 640M 8.35B 652M 638M 27.65B |
| Net income | -160M -137M -129M -117M -222M -15.27B -224M -1.52B -591M -7.7B -601M -588M -25.51B | -115M -98.45M -92.25M -84.27M -159M -10.95B -161M -1.09B -424M -5.53B -431M -422M -18.3B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/08/26 | $1.920 | +3.23% | 1,053,971 |
| 24/08/26 | $1.860 | -5.10% | 845,772 |
| 21/08/26 | $1.960 | +7.69% | 876,794 |
| 20/08/26 | $1.820 | -9.00% | 865,646 |
| 19/08/26 | $2.000 | +3.63% | 792,127 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- KPTI Stock
Select your edition
All financial news and data tailored to specific country editions
